SENECA CAPITAL INVESTMENTS, L.P. - C B PHARMA ACQUISITION CORP ownership

Back to all holdings Add to watchlist

C B PHARMA ACQUISITION CORP's ticker is CNLMU and the CUSIP is G2029P100. A total of 7 filers reported holding C B PHARMA ACQUISITION CORP in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
SENECA CAPITAL INVESTMENTS, L.P. ownership history of C B PHARMA ACQUISITION CORP
ValueSharesWeighting
Q3 2015$1,570,000
-0.6%
150,0000.0%0.56%
+90.5%
Q2 2015$1,579,000
+3.0%
150,0000.0%0.30%
-15.7%
Q1 2015$1,533,000
+1.8%
150,0000.0%0.35%
-15.6%
Q4 2014$1,506,000–150,000–0.42%–
 Download
Other shareholders
C B PHARMA ACQUISITION CORP shareholders Q2 2015
NameSharesValueWeighting ↓
SENECA CAPITAL INVESTMENTS, L.P. 150,000$1,579,0000.30%
GLAZER CAPITAL, LLC 220,260$2,176,0000.24%
Polar Asset Management Partners Inc. 200,000$2,113,0000.09%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 350,000$3,668,0000.06%
GOLDMAN SACHS GROUP INC 17,500$183,0000.00%
Tower Research Capital LLC (TRC) 38$00.00%
UBS Group AG 210$2,0000.00%
View complete list of C B PHARMA ACQUISITION CORP shareholders